cy 208-243 has been researched along with atropine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Durrieu, G; Lataste, X; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM; Tran, MA | 1 |
1 other study(ies) available for cy 208-243 and atropine
Article | Year |
---|---|
Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).
Topics: Antiparkinson Agents; Atropine; Blood Pressure; Epinephrine; Female; Heart Rate; Humans; Indoles; Male; Middle Aged; Norepinephrine; Parkinson Disease; Phenanthridines; Posture; Reference Values | 1990 |